MassBio CEO Kendalle Burlin O’Connell said that without "policy stability and renewed investment," we will cede leadership in ...

At Stanford’s Drug Discovery Symposium, biotech executives spoke openly about how the scientific ecosystem is now in jeopardy ...

The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.

Look for the looming London plane with branches thick as tree trunks. It’s been anchored in East Cambridge for centuries – a ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

Moderna is once again expanding its cost-cutting measures as it seeks to rein in expenses and reach financial breakeven in ...

Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $971 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of ...

Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's ...

Reports first quarter revenues of $0.1 billion, GAAP net loss of $(1.0) billion and GAAP EPS of $(2.52) Reiterates 2025 ...